Dr. Stephen J. Lahey

• 
  www.brooklyneagle.com/categories/category.php?category_ - [Cached Version]
  Published on: 12/7/2008    Last Visited: 12/7/2008  

  "Although Dr. Kantrowitz had the dedication and perseverance to accomplish this remarkable surgical tour de force, it was the notion that, for the first time, science could view the heart as yet another organ that could be fixed that was a revolutionary concept," Dr. Stephen J. Lahey, director of cardiothoracic surgery at Maimonides Medical Center, said in a statement on the 40th anniversary of Dr. Kantrowitz's transplant.

• 
  www.businessweek.com/lifestyle/content/healthday/611495 - [Cached Version]
  Published on: 1/1/2008    Last Visited: 1/14/2008  

  "As far as scientific importance, this is a blockbuster," said Dr. Stephen Lahey, director of cardiac surgery at Maimonides Medical Center in New York City.He suggested that, if the findings are validated by further research, the delivery of the protective factors of the JAK-STAT pathway could be very useful in heart surgery.
  
  For example, if a drug were developed based on the findings, it could be added to the solution that currently is used when stopping a heart during open heart surgery, which would buy more time for the surgeon to complete his work, Lahey explained.Heart surgeons are always operating on the "razor's edge" between having enough time to make needed repairs and the deadline for restarting a heart to prevent fatal damage, he noted.
  
  "Maybe this will be an important arrow in the cardiac surgeon's quiver to protect your heart during surgery and transplants and angioplasty," Lahey said.He added that there is "a possibility this could have widespread use and have a great impact on preserving heart muscle."However, the concept would have to go through very rigorous testing for a long time before it would be in clinical use," Lahey added.
  ...
  SOURCES: Karyn L. Butler, M.D., associate professor, surgery, division of trauma/critical care, University of Cincinnati; Roger Hajjar, M.D., director, Cardiovascular Research Center, Mount Sinai Medical Center, New York City; Stephen Lahey, M.D., professor, surgery, SUNY Downstate Medical Center, and division director, cardiothoracic surgery, Maimonides Medical Center, New York City; January 2008, American Journal of Physiology: Heart and Circulatory Physiology

• 
  www.maimonidesmed.org/body.cfm?id=1549 - [Cached Version]
  Published on: 12/26/2007    Last Visited: 1/27/2008  

  According to Dr. Stephen Lahey, Chief of Cardiothoracic Surgery at Maimonides, "Cardiac surgeons like me proudly stand on the shoulders of innovators like Dr Kantrowitz.
  ...
  In addition to Drs. Berlinerblau, Shani and Lahey, the Maimonides cardiac faculty includes Dr. Joseph Cunningham, Chair of Surgery and Dr. Edgar Lichstein, Chair of Medicine.
  ...
  Dr. Adrian Kantrowitz (right) is presented with a commendation from Dr. Stephen Lahey, Chief of Cardiothoracic Surgery at Maimonides Medical Center.

• 
  www.russellcreekymca.org/index.cfm?FuseAction=Page&Page - [Cached Version]
  Published on: 1/10/2008    Last Visited: 4/10/2008  

  "As far as scientific importance, this is a blockbuster," said Dr. Stephen Lahey, director of cardiac surgery at Maimonides Medical Center in New York City.He suggested that, if the findings are validated by further research, the delivery of the protective factors of the JAK-STAT pathway could be very useful in heart surgery.
  
  For example, if a drug were developed based on the findings, it could be added to the solution that currently is used when stopping a heart during open heart surgery, which would buy more time for the surgeon to complete his work, Lahey explained.Heart surgeons are always operating on the "razor's edge" between having enough time to make needed repairs and the deadline for restarting a heart to prevent fatal damage, he noted.
  
  "Maybe this will be an important arrow in the cardiac surgeon's quiver to protect your heart during surgery and transplants and angioplasty," Lahey said.He added that there is "a possibility this could have widespread use and have a great impact on preserving heart muscle."However, the concept would have to go through very rigorous testing for a long time before it would be in clinical use," Lahey added.

• 
  www.principalhealthnews.com/article/healthday/674995 - [Cached Version]
  Published on: 4/20/2007    Last Visited: 4/20/2007  

  The issue of patient selection is a critical one, agreed Dr. Stephen Lahey, director of cardiothoracic surgery at Maimonides Medical Center in New York City.But he wasn't sure this study answered the question.
  
  "There are people it is absolutely appropriate they should get drug-eluting stents and some it's absolutely appropriate they should get surgery," Lahey said.
  ...
  SOURCES: Muhammad S. Munir, M.D., nonclinical research fellow, Texas Heart Institute, Houston; James Wilson, M.D., program director, cardiology fellowship program, St. Luke's Episcopal Hospital/Texas Heart Institute, Houston; Stephen Lahey, M.D., director, cardiothoracic surgery, Maimonides Medical Center, New York City; April 19, 2007, presentation, American Heart Association annual conference on Arteriosclerosis, Thrombosis and Vascular Biology, Chicago

• 
  www.marcumandwallace.org/national_news_show.asp?id=1178 - [Cached Version]
  Published on: 4/20/2007    Last Visited: 4/20/2007  

  The issue of patient selection is a critical one, agreed Dr. Stephen Lahey, director of cardiothoracic surgery at Maimonides Medical Center in New York City.But he wasn't sure this study answered the question.
  
  "There are people it is absolutely appropriate they should get drug-eluting stents and some it's absolutely appropriate they should get surgery," Lahey said.
  ...
  SOURCES: Muhammad S. Munir, M.D., nonclinical research fellow, Texas Heart Institute, Houston; James Wilson, M.D., program director, cardiology fellowship program, St. Luke's Episcopal Hospital/Texas Heart Institute, Houston; Stephen Lahey, M.D., director, cardiothoracic surgery, Maimonides Medical Center, New York City; April 19, 2007, presentation, American Heart Association annual conference on Arteriosclerosis, Thrombosis and Vascular Biology, Chicago

• 
  www.fullertonheart.com/handler.cfm?event=newsfeed,newsa - [Cached Version]
  Published on: 1/10/2008    Last Visited: 1/11/2008  

  SOURCES: Karyn L. Butler, M.D., associate professor, surgery, division of trauma/critical care, University of Cincinnati; Roger Hajjar, M.D., director, Cardiovascular Research Center, Mount Sinai Medical Center, New York City; Stephen Lahey, M.D., professor, surgery, SUNY Downstate Medical Center, and division director, cardiothoracic surgery, Maimonides Medical Center, New York City; January 2008, American Journal of Physiology: Heart and Circulatory Physiology

• 
  www.chasemedical.com/patient/popup_ne_region.htm - [Cached Version]
  Published on: 12/14/2007    Last Visited: 12/14/2007  

  Stephen Lahey, M.D. Maimonides Medical Center

• 
  www.imageusa.com/communityarticles/communityevents/maim - [Cached Version]
  Last Visited: 6/16/2009  

  Dr. Adrian Kantrowitz is presented with a commendation from Dr. Stephen Lahey, Chief of Cardiothoracic Surgery at Maimonides Medical Center
  ...
  According to Dr. Stephen Lahey, Chief of Cardiothoracic Surgery at Maimonides, "Cardiac surgeons like me proudly stand on the shoulders of innovators like Dr Kantrowitz.
  ...
  In addition to Drs. Berlinerblau, Shani and Lahey, the Maimonides cardiac faculty includes Dr. Joseph Cunningham, Chair of Surgery and Dr. Edgar Lichstein, Chair of Medicine.

• 
  www.stmary4health.com/body.cfm?id=6&action=detail&aepro - [Cached Version]
  Published on: 4/20/2007    Last Visited: 4/20/2007  

  The issue of patient selection is a critical one, agreed Dr. Stephen Lahey, director of cardiothoracic surgery at Maimonides Medical Center in New York City.But he wasn't sure this study answered the question.
  
  "There are people it is absolutely appropriate they should get drug-eluting stents and some it's absolutely appropriate they should get surgery," Lahey said.
  ...
  SOURCES: Muhammad S. Munir, M.D., nonclinical research fellow, Texas Heart Institute, Houston; James Wilson, M.D., program director, cardiology fellowship program, St. Luke's Episcopal Hospital/Texas Heart Institute, Houston; Stephen Lahey, M.D., director, cardiothoracic surgery, Maimonides Medical Center, New York City; April 19, 2007, presentation, American Heart Association annual conference on Arteriosclerosis, Thrombosis and Vascular Biology, Chicago

Page:  1 2 3 4